News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024
Presentation AHA 2024 OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial Presenter: Kausik K. Ray November 17, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Daily News Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime Michael O'Riordan October 14, 2024
News Daily News COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank Todd Neale October 10, 2024
News Conference News ESC 2024 Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events Michael O'Riordan September 01, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea Michael O'Riordan June 21, 2024
News Daily News Excess ApoB Linked to Increased MI, ASCVD Risk in Adults Michael O'Riordan June 04, 2024
News Daily News Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI Michael O'Riordan May 02, 2024
News Daily News Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups Michael O'Riordan April 17, 2024
News Daily News Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank Michael O'Riordan January 23, 2024